Highlights Achilles Therapeutics plc

Equities

ACHL

US00449L1026

Delayed Nasdaq Other stock markets 14:53:00 15/05/2024 BST			5-day change	1st Jan Change
0.92 ^USD	0.00%		+0.12%	+3.49%

05-08	Achilles Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-05	Piper Sandler Downgrades Achilles Therapeutics to Neutral From Overweight, Cuts Price Target to $2 From $8	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Achilles Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
ADRs Close Lower; Moatable Inc. Declines 33.3%	04-04	DJ
Syncona notes investee Achilles's annual loss narrows	04-04	AN
Achilles Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	04-04	CI
Achilles Therapeutics plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	04-04	CI
Achilles Therapeutics plc Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning	04-04	CI
Syncona notes investee company's quarterly loss	11-14	AN
Achilles Therapeutics plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Syncona's portfolio Achilles Therapeutics net loss narrows	04/08/23	AN
Achilles Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/08/23	CI
Syncona say portfolio clinical company Achilles have widened losses	10/05/23	AN
Achilles Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05/23	CI
Achilles Therapeutics plc Announces New Immunogenicity Prediction Application of its AI-Powered PELEUS Platform Uniquely Identifies Most Potent T Cell Antigens	10/05/23	CI
Achilles Therapeutics : Corporate Presentation – March 2023	07/03/23	PU
Achilles Therapeutics plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	07/03/23	CI
Achilles Therapeutics : Corporate Presentation – January 2023	05/01/23	PU
Syncona's Achilles says cancer treatment shows promise; seals buy	01/12/22	AN
Achilles Therapeutics plc Updates Interim Results from the Ongoing Phase I/IIa Chiron and Thetis Clinical Trials	30/11/22	CI
Achilles Therapeutics plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	08/11/22	CI
Achilles Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	09/08/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Achilles Therapeutics plc

Equities

ACHL

US00449L1026

Highlights

Filters